-
| Exchange | NASDAQ |
|---|---|
| CurrencyCode | USD |
| ISIN | US31573L1052 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Beta | nan |
|---|---|
| PE Ratio | None |
| Target Price | 10.75 |
| Market Cap | 49M |
| Dividend Yield | None |
FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The company was founded in 2021 and is based in Houston, Texas.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for FBLG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025